Welldoc, Inc., founded with a mission to empower individuals to self-manage their cardiometabolic conditions, leverages artificial intelligence to provide digital health solutions. The company's core vision is to advance and accelerate cardiometabolic care through AI-driven platforms. Welldoc offers web and mobile applications designed for managing chronic diseases such as diabetes, hypertension, heart failure, weight management, prediabetes, and mental wellbeing. Their market focus includes patients and healthcare providers in Maryland and beyond.
Notable figures affiliated with Welldoc include its founders and key investors who have supported the company's growth. Welldoc has achieved significant milestones, including multiple FDA clearances and numerous clinical publications validating its technology. The company holds several patents for its innovative solutions and has received awards for its AI capabilities. Overall, Welldoc has made a substantial impact by integrating evidence-based care with connected devices and data, enhancing the quality of life for individuals managing chronic conditions.
